Hib Vaccine Liquid Solution - Single Dose Vial for Pneumonia & Meningitis Prevention

SKU: S0001393
REF #: 001607
Short description

Product: Hib Vaccine Liquid Solution: Single Dose Vial. This potent immunization agent comprises of a purified, non-infectious subunit of Haemophilus influenzae type b (Hib) bonded to a diphtheria toxin mutant, CRM 197.

  • Uses: Serves as an effective line of defense against grave diseases such as pneumonia and meningitis via intramuscular injections.
  • Immunization Protocol: Administer in a three-dose primary series with a booster between 12 and 18 months. Compatible with other vaccinations.
  • Side Effects: Rare serious reactions, though mild local responses within a day of injection are possible.
  • Storage: Store and maintain at cool temperatures ranging between 2°C and 8°C. Avoid freezing conditions.
Quantity :
  • Procurenet Team Tshim Sha Tsui
    Hong Kong Hong Kong 3 years
Delivery options
  • 7 Days Return Back Policy
  • 2 Days Cancellation Policy
  • Ship Only

Hib Vaccine Liquid Solution: Single Dose Vial Effective Against Severe Pneumonia and Meningitis

Designed to combat the global threat of Haemophilus influenzae type b (Hib) disease, our Hib Vaccine plays a crucial role in children's health. Hib, a bacterium, triggers severe illnesses, notably pneumonia and meningitis, particularly in children under 5 years old.

Every 0.5ml dose is meticulously prepared from Hib bacteria cultured in a chemically defined medium. Harvested and purified via a high-tech ultrafiltration process, the final vaccine represents a chemically purified, non-infectious Hib capsular polysaccharide, that is covalently linked to CrossReacting Material 197 (CRM 197), a harmless diphtheria toxin mutant that acts as a carrier protein. Each vial keeps freshness with 0.05mg thiomersal.

The Hib Vaccine is designed for intramuscular injection into the anterolateral aspect of the thigh for infants and the deltoid muscle as the preferred site for older children and adults.

Key features:

  • Three-dose primary series designed to coordinate with the primary DTP series.
  • Typically, a booster dose is administered between 12-18 months.
  • Permits co-administration with BCG, DTP, measles, polio vaccines (OPV or IPV), hepatitis B, yellow fever vaccines, and vitamin A supplementation.
  • Minimal side effects with rare severe reactions.
  • Storage and transportation between 2°C to 8°C. Avoid freezing. Opened multi-dose vials should adhere to the same temperature requirements.

Our Hib Vaccine, paramount to preventing Hib diseases, is an asset in maintaining global child health. Adhering to the right vaccination timeline can play an instrumental role in mitigating severe health risks.

All categories